Table 2 Baseline characteristics for individuals that were lost to follow-up and individuals that were analysed, and individuals in the treatment and placebo group
Individuals lost to follow-up (N = 840) | Individuals analysed (N = 388) | P | Treatment Group (N = 194) | Placebo Group (N = 194) | P | |
|---|---|---|---|---|---|---|
Characteristic | ||||||
Age (months) | ||||||
12–23 | 287 (34.2%) | 135 (34.8%) | 0.336* | 72 (37.1%) | 63 (32.5%) | 0.374* |
24–35 | 187 (22.3%) | 101 (26%) | 46 23.7%) | 55 (28.4%) | ||
36–47 | 194 (23.1%) | 86 (22.2%) | 39 (20.1%) | 47 (24.2%) | ||
48–59 | 172 (20.5%) | 66 (17%) | 37 (19.1%) | 29 (14.9%) | ||
Sex | ||||||
Male | 443 (52.7%) | 193 (49.7%) | 0.329* | 103 (53.1%) | 90 (46.4%) | 0.187* |
Female | 397 (47.3%) | 195 (50.3%) | 91 (46.9%) | 104 (53.6%) | ||
Village | ||||||
Akinlalu | 99 (11.8%) | 86 (22.2%) | 0.588* | 43 (22.2%) | 43 (22.2%) | 0.562* |
Ipetumodu | 378 (45%) | 157 (40.5%) | 80 (41.2%) | 77 (39.7%) | ||
Moro | 160 (19%) | 59 (15.2%) | 33 (17%) | 26 (13.4%) | ||
Edun-abon | 203 (24.2%) | 86 (22.2%) | 38 (19.6%) | 48 (24.7%) | ||
Socio-economic status | ||||||
Mean ± SE | 6.49 ± 0.10 | 6.28 ± 0.06 | 0.077┼ | 6.39 ± 0.13 | 6.59 ± 0.15 | 0.324┼ |
Parasitic infections | ||||||
Ascaris lumbricoides | 409 (48.7%) | 176 (45.4%) | 0.277* | 88 (45.4%) | 88 (45.4%) | 1* |
Mean epg ± SE | 1060.69 ± 91.70 | 1111 ± 149.53 | 0.581┼ | 1095.19 ± 237.48 | 1126.81 ± 182.39 | 0.777┼ |
Trichuris trichiura | 34 (4%) | 12 (3.1%) | 1§ | 5 (2.6%) | 7 (3.6%) | 0.558* |
Mean epg ± SE | 5.16 ± 3.07 | 1.70 ± 1.05 | 0.81 ± 0.47 | 2.6 ± 2.06 | ||
Hookworm | 38 (4.5%) | 15 (3.9%) | 0.598* | 5 (2.6%) | 10 (5.2%) | 0.188* |
Mean epg ± SE | 4.86 ± 1.47 | 3.41 ± 1.75 | 3.56 ± 2.91 | 3.26 ± 1.97 | ||
Schistosoma haematobium | 7 (.8%) | 7 (1.8%) | 0.153§ | 3 (1.5%) | 4 (2.1%) | 1§ |
Mean epg ± SE | 0.02 ± 0.01 | 0.06 ± 0.02 | 0.06 ± 0.04 | 0.06 ± 0.03 |